Differential expression of Fas ligand in Th1 and Th2 cells is regulated by early growth response gene and NF-AT family members

Journal of Immunology

Volumn 166, Issue 7, 2001, Pages 4534-4542

  Dzialo Hatton, R ^a   Milbrandt, J ^a   Hockett R D , Jr ^a   Weaver, C T ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MOUSE; MULTIGENE FAMILY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 0035313050     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.7.4534     Document Type: Article

References (58)

1. Apoptosis by death factor
2. Activatior-induced apoptosis in lymphocytes
3. Activation-induced death of mature T cells in the regulation of immune responses
4. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
5. Fas ligand mediates activation-induced cell death in human T lymphocytes
6. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
7. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
8. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis family
9. + T lymphocytes from HIV-infected
10. A role for CD95 ligand in preventing graft rejection
11. Fas ligand-induced apoptosis as a mechanism of immune privilege
12. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
13. Expression of the Fas ligand in cells of T cell lineage
14. Unequal death in T helper cell Th1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis
15. Differential ability of Th1 and Th2 cells to express Fas ligand and to undergo activation-induced cell death
16. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids
17. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A
18. Activation-induced cell death in murine T cell hybridomas: Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506
19. Transcription factors of the NFAT family: Regulation and function
20. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells
21. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events
22. Transcriptional regulation of the human FasL promoter-enhancer region
23. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR mediated activation
24. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development
25. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice
26. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression
27. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells
28. Novel Egr/NFAT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation
29. Utilization of an NF-ATp binding promoter element for Egr-3 expression in T cells but not fibroblasts provides a molecular model for the lymphoid cell-specific effect of cyclosporin A
30. Sequential involvement of NFAT and Egr transcription factors in FasL regulation
31. Stress induced Fas ligand expression in T cells is mediated through a MEK kinase 1 regulated response element in the Fas ligand promoter
32. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1
33. lo thymocytes in vivo
34. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
35. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody
36. Heterogeneity of single-cell cytokine gene expression in clonal T cell populations
37. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1
38. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice
39. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling
40. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor
41. DNA-binding specificity of NGFI-A and related zinc finger transcription factors
42. Structure, chromosome location, and expression of the mouse zinc finger gen Krox-20: Multiple gene products and coregulation with the protooncogene c-fos
43. Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity
44. Constitutive Fas ligand gene transcription in Sertoli cells is regulated by Sp1
45. Human Fas ligand: Gene structure, chromosomal location, and species specificity
46. Expression of PILOT, a putative transcription factor, requires two signals and is cyclosporin A sensitive in T cells
47. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia
48. A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes
49. The regulation of CD95 (Fas) ligand expression in primary T cells: Induction of promoter activation in CD95LP-Luc transgenic mice
50. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc
51. Sp3 represses transcription when tethered to promoter DNA or targeted to promoter proximal RNA
52. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells
53. Inhibition of the ReIA(p65) NF-κB subunit by Egr-1
54. Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3
55. Identification of NABI, a repressor of NGFI-A and Krox20-mediated transcription
56. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli
57. A novel activation function for NAB proteins in EGR-dependent transcription of the luteinizing hormone β gene
58. Long-range transcriptional regulation of cytokine gene expression